FDA Investigator Melvin Dorin
Melvin Dorin has inspections in 1 countries as of 30 Oct 2023. Melvin Dorin has collaborated with a combined 1292 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
18
Last Inspection Date:
30 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
A Williams,
Angel K Sandhu,
Bak,
Barbara J Arrais,
Blair,
Bruce D Broidy,
Capri R Woolridge,
Carr,
Chloe Anne Leong,
Christine M Parmentier,
Christopher J Lee,
Cindy W Lewis,
Courtney R Bolton,
Daniel C Geffin,
Daniel Velasquez,
Darla R Bracy,
Davina M Martinez,
Edna J Hidalgo,
Elodie Xtong Lin,
Elsa Y Yu,
Emal Wahab,
Eric J Heinze,
Eric W Anderson,
Greg K Keshishyan,
Harperd,
Indigo A Doll,
Janice R Small,
Janice Wai,
Jeanne A Young,
Jeffrey W Shrifter, DPM,
John Cheung,
Juan A Morales,
Jude C Dikes,
Juliane Kjung Lau,
Kacie M Crowther,
Karen D Phung,
Kevin T Gerrity,
Kimberly L Anderson,
Larkin R Buckalew,
Lawton W Lum,
Lealand Lee,
Leongc,
Linda S Shook,
Liu,
Lorraine N Williams,
LT Mark A Chen, MPH,
Mabel M Lee,
Macropolk,
Maida Henesian (NMI),
Marissa J Chan,
Mark I Nakano,
Mark L Collins,
Matthew A Walburger,
Mcgrewp,
Megan E Kulas,
Melody M Ragasa Leong,
Michael T Macia,
Monique C Lo,
Ngoc B Kelsch,
Nianna C Burns,
Nympha V Florendo,
Peter E Baker,
Randal Anderson,
Randall J Plunkett,
Rashonda N Rucker,
Raymond Souweha,
Roberta K Smith,
Robin T Gilb,
Roger D Gawne,
Ronald P Boyce,
Siobhan A Gallagher,
State Agency,
Stephen R Souza,
Steve P Yost,
Steven R Gillenwater,
Terrence Gee,
Tomanik'e C Banks,
Victoria L Morgan,
Wayne L Jefferson,
Wen Jun Peng,
William J Weis
Melvin Dorin's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2002 | FDA 483 | Medtronic Spine LLC - Form 483, 2002-05-28 |
March, 2002 | FDA 483 | Cardiovention, Incorporated - Form 483, 2002-03-12 |
May, 2002 | FDA 483 Response | Medtronic Spine LLC - Form 483R, 2002-06-26 |
February, 2002 | FDA 483 | ABB Concise Optical Group LLC - Form 483, 2002-02-11 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more